Glycerin 2.1 g Suppository, 25 suppositories
by Amerisource Bergen/Good Neighbor Pharmacy · 25 SUPPOSITORY in 1 JAR (46122-221-63)
NDC 46122-0221-63
🏷️ FDA NDC (as labeled)
46122-221-63
billing pads the product segment with a zero
This package
Contains25 suppositories
Cost per ea$0.1030 NADAC
Per package$2.58 / 25 suppositories
Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.3754/unit — full pricing hub ↓
Also comes in:
50 suppositories 46122-0221-71
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Glycerin (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 27, 2026 — Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. (Oasis Medical, Inc.) · FDA recall D-0525-2026
Class II · Apr 20, 2026 — Lack of Assurance of Sterility (SCOPE HEALTH) · FDA recall D-0499-2026
Class II · Mar 25, 2026 — Lack of Assurance of Sterility (Preferred Pharmaceuticals, Inc.) · FDA recall D-0443-2026
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0411-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
🆔 Identity & classification
FDA NDC (as labeled)
46122-221-63
Product NDC
46122-221
11-digit billing NDC
46122022163
NCPDP billing unit
EA — each (per item)
RxCUI
583084
UNII
PDC6A3C0OX
Application #
M007
SPL Set ID
e6a8914f-cfd9-4c72-abaa-22189bf0faef
Established class (EPC)
Non-Standardized Chemical Allergen
Physiologic effect
Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class
Allergens; Glycerol
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2013-09-12
Route
RECTAL
Dosage form
SUPPOSITORY
Substance
GLYCERIN
GPI-14
46600010005250
GPI class
GNP Glycerin (Adult)
GCN Seq No
002982
GCN
08860
HICL code
001312
Ingredient (HICL)
Glycerin
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q3
Therapeutic class — intermediate (HIC2)
Anal-Rectal Preparations
HIC3 code
Q3S
Therapeutic class — specific (HIC3)
Laxatives, Local/Rectal
AHFS code
56:12.00.00
AHFS class
Cathartics And Laxatives
FDB label name
GLYCERIN SUPPOSITORY
FDB brand name
Glycerin
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 46122-221-63 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0221-63. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Non-Standardized Chemical Allergen class.
Pharmacologic class
Non-Standardized Chemical Allergen
Drug family (ATC)
Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerAmerisource Bergen/Good Neighbor Pharmacy
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code46122
First marketedSep 2013
Product typeHuman Otc Drug
Portfolio2 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name GLYCERIN SUPPOSITORY Ingredient Glycerin
🧪 What is this product?
Glycerin 2.1 g/1 Suppository is an over-the-counter rectal suppository containing glycerin as its active ingredient. Glycerin is commonly used in suppository form to help soften stool and promote bowel movements. This product is marketed as an OTC monograph drug, meaning it follows FDA's established rules for its category rather than undergoing individual product review. Suppositories of this type are typically used to address occasional constipation or to facilitate bowel regularity.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Glycerin — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Glycerin?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 55X04QC32I
A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
-
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statespurified water, sodium hydroxide, stearic acid
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.103 | $2.58 / 25 suppositories |
| Medicaid paysCMS SDUD · 12 mo | $0.3754 | $9.39 / 25 suppositories |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
▲ Up 19% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Glycerin 2.1 gthis 46122-0221-63 | Amerisource | 25 suppositories | $0.103 | — | Availability likely | — |
| Glycerin 2.1 g 52316-0723-25 | DSC | 25 suppositories | — | — | FDA listed | — |
| Glycerin 2.1 g 52316-0725-50 | DSC | 50 suppositories | — | — | FDA listed | — |
| Glycerin 2.1 g 63868-0283-25 | Chain | 25 suppositories | — | — | FDA listed | — |
| Glycerin 2.1 g 83324-0284-25 | Chain | 25 suppositories | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2013
On the market since
Sep 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 46122-0221-63, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
92
Units reimbursed last 4 qtrs
1.5K
Gross reimbursed last 4 qtrs
$574.69
Avg / prescription
$6.25
Avg / unit
$0.3754
Latest quarter Q1 2026
12Rx
Medicaid pays / ea
$0.3754
gross reimbursed
vs
NADAC / ea
$0.1030
acquisition cost
=
Spread
+$0.2724
+264% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 0 Rx Managed care · 92 Rx
State Medicaid map
Units reimbursed · per 100k residents
14.221.0
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
💊 Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 92 Rx · 1,531 units · $575 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Glycerin — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 27%
Female · 73%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Status |
|---|---|---|---|---|---|
| 46122-0221-63 You're viewing this | 25 SUPPOSITORY in 1 JAR (46122-221-63) | $0.1030 / ea | $2.57 | 2013-09-12 | Active |
| 46122-0221-71 | 50 SUPPOSITORY in 1 JAR (46122-221-71) | $0.0679 / ea | $3.39 | 2013-09-12 | Active |
You're viewing the smallest of 2 pack sizes for this product.
Per ea, this pack runs about 52% above the cheapest pack (50-count, $0.0679 vs $0.1030 NADAC).
Pack size FAQ
What quantity is in NDC 46122-0221-63?
NDC 46122-0221-63 contains 25 suppositories — 25 suppository in 1 jar.
What is the difference between NDC 46122-0221-63 and NDC 46122-0221-71?
Both are Glycerin 2.1 g Suppository — the drug itself is identical. NDC 46122-0221-63 is the 25 suppositories package, while NDC 46122-0221-71 is the 50 suppositories package. Per-ea NADAC also differs: $0.1030 here vs $0.0679 for the 50 suppositories pack.
What NDC number is used to bill for this package of Glycerin 2.1 g Suppository?
Bill NDC 46122-0221-63 — the 11-digit billing format is 46122022163. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses for relief of occasional constipation this product generally produces a bowel movement in 1/4 to 1 hour
⏱️ Dosage and Administration ▾
Directions Single daily dosage adults and children 6 years and over 1 suppository, or as directed by a doctor children 2 to under 6 years use Child Suppositories Insert suppository well up into rectum. Suppository need not melt completely to produce laxative action.
⚠️ Warnings ▾
Warnings For rectal use only May cause rectal discomfort of burning sensation Ask a Doctor before using any laxative if you have abdominal pain, nausea or vomiting a sudden change in bowel habits lasting more than two weeks already used a laxative for more than 1 week Stop use and consult a doctor if you have rectal bleeding no bowel movement after using this product These symptoms may indicate a serious condition. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredient (in each suppository) Glycerin 2.1 g
🧪 Inactive Ingredients ▾
Inactive ingredients purified water, sodium hydroxide, stearic acid
🎯 Purpose ▾
Purpose Laxative
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.